HomeCYTK • NASDAQ
add
Cytokinetics, Inc.
$55.97
Makalipas ang Oras ng Trabaho:(0.027%)+0.015
$55.98
Sarado: Hul 12, 4:11:02 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$56.30
Sakop ng araw
$55.54 - $57.40
Sakop ng taon
$25.98 - $110.25
Market cap
6.49B USD
Average na Volume
2.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 835.00K | -81.90% |
Gastos sa pagpapatakbo | 45.50M | -8.39% |
Net na kita | -135.64M | -3.32% |
Net profit margin | -16.24K | -470.78% |
Kita sa bawat share | -1.33 | 3.62% |
EBITDA | -123.90M | -1.04% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 618.96M | -6.78% |
Kabuuang asset | 808.08M | -9.19% |
Kabuuang sagutin | 1.20B | 7.63% |
Kabuuang equity | -396.16M | — |
Natitirang share | 104.85M | — |
Presyo para makapag-book | -14.89 | — |
Return on assets | -38.67% | — |
Return on capital | -86.54% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -135.64M | -3.32% |
Cash mula sa mga operasyon | -129.51M | -5.91% |
Cash mula sa pag-invest | 32.64M | -80.28% |
Cash mula sa financing | 103.79M | 1,546.16% |
Net change in cash | 6.95M | -80.71% |
Malayang cash flow | -86.91M | -4.25% |
Tungkol
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
Itinatag
1997
Headquarters
Website
Mga Empleyado
423